Quanta Therapeutics, Inc.
Allosteric small molecule inhibitors targeting KRAS mutations
- Sector
- Biotech
- Headquarters
- SOUTH SAN FRANCISCO, CA
- Founded
- 2018
- Latest Form D
- $50.7M, May 2023
- Total capital
- $121M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $121M
- 3 Form D · last May 2023
- 41 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 5
- 35 pending · first 2022
- Rank in peer group#269 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$50.7M
- Private capital raisedForm D · SEC · 2nd filing$30M
- Private capital raisedForm D · SEC · 1st filing$40.2M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#269 · top 19%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Arjun GoyalDirectorNamed in SEC Form D filings
- Cameron PittExecutive Officer, DirectorNamed in SEC Form D filings
- Derek MetzgerExecutive OfficerNamed in SEC Form D filings
- Leonardo FaoroExecutive OfficerNamed in SEC Form D filings
- Maha KatabiDirectorNamed in SEC Form D filings
- Maria FardisDirectorNamed in SEC Form D filings
Show all 10 people
- Perry NisenExecutive Officer, DirectorNamed in SEC Form D filings
- Rajul JainDirectorNamed in SEC Form D filings
- Samuel SaksDirectorNamed in SEC Form D filings
- Ying HuangDirectorNamed in SEC Form D filings
What it has protected
USPTO · 5 granted of 40- GrantedKras Modulators And Uses ThereofUSPTOUS 12,624,052
- PendingKras Modulators And Uses ThereofUSPTOApplication 19235385
- GrantedKras Modulators And Uses ThereofUSPTOUS 12,421,254
Show all 40 patent records
- Kras Modulators And Uses ThereofMay 12, 2026 · US 12,624,052Granted
- Kras Modulators And Uses ThereofJan 8, 2026 · Application 19235385Pending
- Kras Modulators And Uses ThereofSep 23, 2025 · US 12,421,254Granted
- Pyrimidine Based Modulators And Uses ThereofJul 31, 2025 · Application 18882405Pending
- Pyrimidine Based Modulators And Uses ThereofNov 19, 2024 · US 12,145,947Granted
- Pyrimidine Based Ras Modulators And Uses ThereofOct 3, 2024 · Application 18482674Pending
- Kras Modulators And Uses ThereofFeb 27, 2024 · US 11,912,723Granted
- Compositions And Methods For Identification Of Modulators Of Ras Protein ComplexesAug 17, 2023 · Application 17808450Pending
- Methods And Devices For Detection Of Peripheral Membrane Protein Interactions Using Nonlinear Optical TechniquesAug 17, 2023 · Application 17934829Pending
- Methods And Devices For Detection Of Peripheral Membrane Protein Interactions Using Nonlinear Optical TechniquesNov 1, 2022 · US 11,486,881Granted
- Systems And Methods For High Throughput Analysis Of Conformation In Biological EntitiesFeb 27, 2020 · Application 16562223Pending
- Kras Modulators And Uses ThereofApplication PCTUS2024044284Pending
- Kras Modulators And Uses ThereofApplication PCTUS2024043892Pending
- Combination Therapies With Kras ModulatorsApplication PCTUS2024041318Pending
- Combination Therapies With Kras ModulatorsApplication PCTUS2024041363Pending
- Pyrimidine Based Modulators And Uses ThereofApplication PCTUS2024033907Pending
- Kras Modulators And Uses ThereofApplication PCTUS2024020319Pending
- Combination Therapies With Kras ModulatorsApplication 63600143Pending
- Kras Modulators And Uses ThereofApplication 63579356Pending
- Kras Modulators And Uses ThereofApplication PCTUS2026016446Pending
- Kras Modulators And Uses ThereofApplication 63763796Pending
- Kras Modulators And Uses ThereofApplication 63579351Pending
- Kras Modulators And Uses ThereofApplication 63579226Pending
- Combination Therapies With Kras ModulatorsApplication 63518177Pending
- Combination Therapies With Kras ModulatorsApplication 63518171Pending
- Kras Modulators And Uses ThereofApplication 63508213Pending
- Pyrimidine Based Modulators And Uses ThereofApplication 63507909Pending
- Pyrimidine Based Modulators And Uses ThereofApplication PCTUS2023023445Pending
- Kras Modulators And Uses ThereofApplication 63490475Pending
- Pyrimidine Based Modulators And Uses ThereofApplication 63486934Pending
- Kras Modulators And Uses ThereofApplication PCTUS2023062235Pending
- Kras Modulators And Uses ThereofApplication PCTUS2022081393Pending
- Kras Modulators And Uses ThereofApplication 63384374Pending
- Pyrimidine Based Modulators And Uses ThereofApplication 63380544Pending
- Kras Modulators And Uses ThereofApplication 63378843Pending
- Kras Modulators And Uses ThereofApplication 63373302Pending
- Kras Modulators And Uses ThereofApplication 63371987Pending
- Kras Modulators And Uses ThereofApplication 63368584Pending
- Kras Modulators And Uses ThereofApplication 63367560Pending
- Kras Modulators And Uses ThereofApplication PCTUS2022032680Pending
Related companies, and why
- iTeos TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Star TherapeuticsSimilar federal contract value in Biotech · null in contracts
- NextPoint TherapeuticsSimilar federal contract value in Biotech · null in contracts
- UroGen Pharma Ltd.Similar federal contract value in Biotech · null in contracts
- ANAGINSimilar federal contract value in Biotech · null in contracts
- Scipher Medicine CorpSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .